Contact Us

[New Product] Beilu Pharmaceutical's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Approved

2025/12/13


Recently, Beijing Beilu Pharmaceutical Co., Ltd. received the Drug Registration Certificate issued by the National Medical Products Administration (NMPA) for Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets (15 mg/500 mg).


pioglitazone-metformin-tablets-approval-1011.webp

References
Related Products
Related News